Nami Nishikiori

476 total citations
31 papers, 380 citations indexed

About

Nami Nishikiori is a scholar working on Molecular Biology, Ophthalmology and Neurology. According to data from OpenAlex, Nami Nishikiori has authored 31 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Ophthalmology and 9 papers in Neurology. Recurrent topics in Nami Nishikiori's work include Retinal Diseases and Treatments (9 papers), Barrier Structure and Function Studies (7 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Nami Nishikiori is often cited by papers focused on Retinal Diseases and Treatments (9 papers), Barrier Structure and Function Studies (7 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Nami Nishikiori collaborates with scholars based in Japan. Nami Nishikiori's co-authors include Norimasa Sawada, Makoto Osanai, Takashi Kojima, Hideki Chiba, Masaki Murata, Hiroshi Ohguro, Yoshinori Mitamura, Megumi Watanabe, Masato Furuhashi and Tatsuya Sato and has published in prestigious journals such as Diabetes Care, Cancer Research and Diabetes.

In The Last Decade

Nami Nishikiori

28 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nami Nishikiori Japan 8 208 120 60 58 48 31 380
Orie Nakamura Japan 12 122 0.6× 45 0.4× 111 1.9× 21 0.4× 29 0.6× 20 375
Kathleen Jee United States 9 221 1.1× 33 0.3× 171 2.9× 110 1.9× 18 0.4× 15 440
Yaping Sun United States 10 243 1.2× 31 0.3× 17 0.3× 44 0.8× 29 0.6× 14 440
Houda Tahiri Canada 12 259 1.2× 45 0.4× 177 3.0× 87 1.5× 23 0.5× 29 444
Mathew Nightingale Canada 10 387 1.9× 32 0.3× 29 0.5× 35 0.6× 101 2.1× 14 625
Shoubi Wang China 12 231 1.1× 23 0.2× 92 1.5× 107 1.8× 28 0.6× 19 388
Shira Hagbi-Levi Israel 10 154 0.7× 106 0.9× 279 4.7× 46 0.8× 20 0.4× 17 449
Shuxin Fan China 12 271 1.3× 18 0.1× 76 1.3× 130 2.2× 21 0.4× 19 427
Mario Buono United Kingdom 10 178 0.9× 28 0.2× 61 1.0× 16 0.3× 28 0.6× 14 388
Svetlana Navitskaya United States 9 228 1.1× 53 0.4× 133 2.2× 74 1.3× 5 0.1× 11 339

Countries citing papers authored by Nami Nishikiori

Since Specialization
Citations

This map shows the geographic impact of Nami Nishikiori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nami Nishikiori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nami Nishikiori more than expected).

Fields of papers citing papers by Nami Nishikiori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nami Nishikiori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nami Nishikiori. The network helps show where Nami Nishikiori may publish in the future.

Co-authorship network of co-authors of Nami Nishikiori

This figure shows the co-authorship network connecting the top 25 collaborators of Nami Nishikiori. A scholar is included among the top collaborators of Nami Nishikiori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nami Nishikiori. Nami Nishikiori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
4.
Ohguro, Hiroshi, Megumi Watanabe, Tatsuya Sato, et al.. (2024). Application of Single Cell Type-Derived Spheroids Generated by Using a Hanging Drop Culture Technique in Various In Vitro Disease Models: A Narrow Review. Cells. 13(18). 1549–1549. 7 indexed citations
5.
Watanabe, Megumi, et al.. (2024). Differential Effects of Benzalkonium Chloride on Human Trabecular Meshwork Cells Not Treated or Treated with Transforming Growth Factor-β2 or Dexamethasone. Journal of Ocular Pharmacology and Therapeutics. 40(3). 189–196. 1 indexed citations
7.
Nishikiori, Nami, Megumi Watanabe, Tatsuya Sato, et al.. (2024). Significant and Various Effects of ML329-Induced MITF Suppression in the Melanoma Cell Line. Cancers. 16(2). 263–263. 3 indexed citations
8.
Watanabe, Megumi, et al.. (2024). Unexpected and Synergistical Effects of All-Trans Retinoic Acid and TGF-β2 on Biological Aspects of 2D and 3D Cultured ARPE19 Cells. Biomedicines. 12(10). 2228–2228. 2 indexed citations
9.
Ohguro, Hiroshi, Megumi Watanabe, Fumihito Hikage, et al.. (2024). Fatty Acid-Binding Protein 4-Mediated Regulation Is Pivotally Involved in Retinal Pathophysiology: A Review. International Journal of Molecular Sciences. 25(14). 7717–7717. 3 indexed citations
10.
Nishikiori, Nami, Kohichi Takada, Tatsuya Sato, et al.. (2023). Physical Properties and Cellular Metabolic Characteristics of 3D Spheroids Are Possible Definitive Indices for the Biological Nature of Cancer-Associated Fibroblasts. Cells. 12(17). 2160–2160. 3 indexed citations
11.
Watanabe, Megumi, et al.. (2023). TGF-β Isoforms Affect the Planar and Subepithelial Fibrogenesis of Human Conjunctival Fibroblasts in Different Manners. Biomedicines. 11(7). 2005–2005. 4 indexed citations
12.
Nishikiori, Nami, Tatsuya Sato, Megumi Watanabe, et al.. (2023). Three-Dimensional Spheroid Configurations and Cellular Metabolic Properties of Oral Squamous Carcinomas Are Possible Pharmacological and Pathological Indicators. Cancers. 15(10). 2793–2793. 7 indexed citations
13.
Osanai, Makoto, Nami Nishikiori, Gang‐Hong Lee, & Norimasa Sawada. (2010). Emerging Novel Treatment Strategies for Diabetic Eye Diseases. Current Diabetes Reviews. 6(1). 35–41. 7 indexed citations
14.
Nishikiori, Nami. (2008). An intractable case of Pseudomonas aeruginosa infection after scleral buckling for rhegmatogenous retinal detachment. Clinical ophthalmology. 2(1). 223–223. 3 indexed citations
15.
Nishikiori, Nami, Norimasa Sawada, & Hiroshi Ohguro. (2008). Prevention of murine experimental corneal trauma by epigenetic events regulating claudin 6 and claudin 9. Japanese Journal of Ophthalmology. 52(3). 195–203. 10 indexed citations
16.
Nishikiori, Nami. (2008). Experimental effect of retinoic acids on apoptosis during the development of diabetic retinopathy. Clinical ophthalmology. 2(1). 233–233. 8 indexed citations
17.
Nishikiori, Nami, Makoto Osanai, Hideki Chiba, et al.. (2007). Glial Cell–Derived Cytokines Attenuate the Breakdown of Vascular Integrity in Diabetic Retinopathy. Diabetes. 56(5). 1333–1340. 66 indexed citations
18.
Osanai, Makoto, Nami Nishikiori, Masaki Murata, et al.. (2006). Occludin expression inhibits tumorigenicity and metastasis. The FASEB Journal. 20(4). 1 indexed citations
19.
Osanai, Makoto, Nami Nishikiori, Masaki Murata, et al.. (2006). Cellular Retinoic Acid Bioavailability Determines Epithelial Integrity: Role of Retinoic Acid Receptor α Agonists in Colitis. Molecular Pharmacology. 71(1). 250–258. 84 indexed citations
20.
Osanai, Makoto, Hideki Chiba, Nami Nishikiori, et al.. (2005). Glyceraldehyde-derived advanced glycation end-products preferentially induce VEGF expression and reduce GDNF expression in human astrocytes. Biochemical and Biophysical Research Communications. 330(2). 361–366. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026